University of Brescia and Mount Sinai Expand Cooperation with First Internationalization Summit
Faculty from the Icahn School of Medicine at Mount Sinai joined colleagues from around the world at the University of Brescia in Italy for a recent conference on the internationalization of education and research. The 2016 Brescia Internationalization Summit, held on July 13, 2016, included a roundtable discussion where participants explored the university's role in creating a new generation of globally minded professionals for the advancement of science.
The special relationship between the Icahn School of Medicine at Mount Sinai and the University of Brescia was formed in 2013 to facilitate international scientific collaboration with special emphasis on the prevention of acute and chronic diseases.
Participating Mount Sinai faculty included Robert Wright, MD, MPH, Ethel H. Wise Professor and Chair, Department of Environmental Medicine and Public Health, and Professor of Pediatrics, Icahn School of Medicine at Mount Sinai; Roberto Lucchini, MD, Director, Division of Occupational and Environmental Medicine, Department of Environmental Medicine and Public Health; Manish Arora, PhD, BDS, MPH, Director of Exposure Biology at the Senator Frank Lautenberg Environmental Health Sciences Laboratory, Department of Environmental Medicine and Public Health, and Avi Reichenberg, PhD, Professor of Psychiatry, Icahn School of Medicine.
The summit also included discussions highlighting the benefits of international education, policies related to credentialing for visiting academics, and the importance of providing comprehensive logistical support and hospitality for visitors. Participants agreed that healthy competition between individual universities must be matched by effective collaboration between the different networks to enable the whole system to be competitive.
“Internationalization means, above all, a new mindset and opening to the world system and the global dimension,” said Sergio Pecorelli ,MD, Chancellor of the University of Brescia. “This necessary renewal, which recalls the original vocation of European universities at the end of the Middle Ages, aims to educate citizens who are able to develop higher awareness and are better prepared and ready to face the professional and cultural challenges of the Future Society.”
“Internationalization in higher education has become a top priority for universities everywhere,” said Dr. Lucchini, who holds faculty positions at both the Icahn School of Medicine at Mount Sinai and the University of Brescia. “Developing effective programs that facilitate collaboration between researchers at institutions halfway around the world is redefining how we teach and do research.”
- Dr. Lucchini hosted a tour and meeting at Mount Sinai with Italian Minister of Health Beatrice Lorenzin and Chancellor Pecorelli (New York, June 2014).
- Collaborative exchanges between Icahn School of Medicine and University of Brescia faculty and medical residents in occupational and environmental health (ongoing), rehabilitation and physiotherapy (2014), neuroanesthesia and neurointensive care (2014), hematology (2015), cardiology (2015), geriatrics (2015-16), and head and neck surgery (2016).
- The 2016 Brescia Conference – first Internationalization Summit (Italy, July 13, 2016)
Other institutions represented at the conference included the University of Trento, University of Sydney, INEFC (Barcelona), University of Valencia, GUtech (Oman), King’s College (London), University of California (Irvine, Santa Cruz), Burapha University (Bangkok) and Rutgers University (New Jersey).
Following the conference, participants joined a multidisciplinary workshop on the need for prevention in early life to ensure healthy development and aging. Topics addressed included:
- Importance of the first 1,000 days paradigm (Sergio Pecorelli, Chancellor, University of Brescia)
- Sensitive exposure windows for early life toxicity (Robert Wright, Icahn School of Medicine at Mount Sinai
- Shed teeth assessment as new biomarkers (Manish Arora, Icahn School of Medicine at Mount Sinai)
- Environmental and genetic determinants of developmental disorders (Avi Reichenberg, Icahn School of Medicine at Mount Sinai)
- Visual assessment in newborns as a tool for early neurodevelopmental diagnosis (Elisa Fazzi, University of Brescia)
- Environmental health strategy of the Italian Ministry of Health (Ranieri Guerra, Italian Ministry of Health)
- From neurodevelopment to neurodegeneration in the province of Brescia (Roberto Lucchini, University of Brescia, Icahn School of Medicine at Mount Sinai
About University of Brescia, Italy
The University of Brescia is an Italian public University that works in the following four macro areas: Medicine, Engineering, Economics and Law. The eight departments represent the disciplines that build the cultural fundamentals of the macro areas and host 600 professors and researchers, as well as a large group of post-doctoral researchers. There are approximately 15,000 undergraduate and Master Degree students, PhD, and medical residents. The administrative and research structure contains 500 technical and administrative professionals. Health&Wealth is the new thematic project the University of Brescia. It is grounded in new knowledge, research, culture, health, wellbeing, technology and progress. Health&Wealth is a project aimed at the transformation of both our way of living and of thinking, such that economic and industrial systems can thrive while respecting culture, people, and the environment.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology and the South Nassau Communities Hospital is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and South Nassau Communities Hospital are ranked regionally.